Beth Israel registers Phase II lifileucel TIL trial for kidney cancer with IovanceNov 9Trial updatealdesleukinIovance Biotherapeutics, Inc.
Pfizer raises 2026 guidance after Q3, reports pipeline progress and new CFONov 3Quarterly updateBioNTech SEC4 Therapeutics, Inc.
Iovance registers Phase 2 lifileucel trial in advanced soft tissue sarcoma, 'SARATOGA'Oct 9Trial updateIovance Biotherapeutics, Inc.lifileucel
Iovance lifts 2026 revenue guidance to $410-420 millionSep 29FinancingaldesleukinIovance Biotherapeutics, Inc.
Iovance posts record Q2 2026 revenue, gains FDA fast track for lifileucel in sarcomasAug 6Quarterly updateIovance Biotherapeutics, Inc.lifileucel
Iovance registers two new trials: IOV-5001 solid tumor study and lifileucel sarcoma trialAug 4Weekly roundup, 2 itemsIOV-5001Iovance Biotherapeutics, Inc.
Iovance's cervical cancer TIL trial C-145-04 terminated after meeting event thresholdJul 31Trial updateIovance Biotherapeutics, Inc.lifileucel
FDA advisory committee backs RP1 efficacy data in advanced melanoma, 10-3Jul 30Regulatory milestoneReplimune, Inc.
Penn Medicine registers PICSTAT pilot testing CD8 PET imaging with Iovance's lifileucelJul 13Trial updateIovance Biotherapeutics, Inc.lifileucel